KR100986249B1 - Spectrum extract and natural antibacterial and antiseptic composition using the same. - Google Patents
Spectrum extract and natural antibacterial and antiseptic composition using the same. Download PDFInfo
- Publication number
- KR100986249B1 KR100986249B1 KR1020080022266A KR20080022266A KR100986249B1 KR 100986249 B1 KR100986249 B1 KR 100986249B1 KR 1020080022266 A KR1020080022266 A KR 1020080022266A KR 20080022266 A KR20080022266 A KR 20080022266A KR 100986249 B1 KR100986249 B1 KR 100986249B1
- Authority
- KR
- South Korea
- Prior art keywords
- extract
- weight
- cinnamon
- cosmetic composition
- lotus leaf
- Prior art date
Links
- 239000000284 extract Substances 0.000 title claims abstract description 81
- 239000000203 mixture Substances 0.000 title claims abstract description 34
- 230000000844 anti-bacterial effect Effects 0.000 title claims abstract description 19
- 230000002421 anti-septic effect Effects 0.000 title claims abstract description 19
- 238000001228 spectrum Methods 0.000 title description 6
- 239000002537 cosmetic Substances 0.000 claims abstract description 37
- 230000000845 anti-microbial effect Effects 0.000 claims abstract description 30
- 240000002853 Nelumbo nucifera Species 0.000 claims abstract description 21
- 235000006508 Nelumbo nucifera Nutrition 0.000 claims abstract description 21
- 235000006510 Nelumbo pentapetala Nutrition 0.000 claims abstract description 20
- 235000020230 cinnamon extract Nutrition 0.000 claims abstract description 19
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 11
- 230000003595 spectral effect Effects 0.000 claims description 10
- 238000009472 formulation Methods 0.000 claims description 8
- 239000006071 cream Substances 0.000 claims description 4
- 235000002789 Panax ginseng Nutrition 0.000 claims description 2
- 239000006260 foam Substances 0.000 claims description 2
- 239000006210 lotion Substances 0.000 claims description 2
- 235000013336 milk Nutrition 0.000 claims description 2
- 239000008267 milk Substances 0.000 claims description 2
- 210000004080 milk Anatomy 0.000 claims description 2
- 239000003755 preservative agent Substances 0.000 abstract description 25
- 230000002335 preservative effect Effects 0.000 abstract description 15
- 244000223760 Cinnamomum zeylanicum Species 0.000 abstract description 7
- 235000017803 cinnamon Nutrition 0.000 abstract description 7
- 241000196324 Embryophyta Species 0.000 abstract description 4
- 239000000419 plant extract Substances 0.000 abstract description 4
- 239000002994 raw material Substances 0.000 abstract description 4
- 239000002131 composite material Substances 0.000 abstract description 3
- 235000020095 red wine Nutrition 0.000 abstract 2
- 230000002079 cooperative effect Effects 0.000 abstract 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 23
- 241000894006 Bacteria Species 0.000 description 21
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 19
- 229920001817 Agar Polymers 0.000 description 12
- 239000008272 agar Substances 0.000 description 12
- 239000000839 emulsion Substances 0.000 description 12
- 241000191967 Staphylococcus aureus Species 0.000 description 11
- 239000000047 product Substances 0.000 description 11
- 230000002829 reductive effect Effects 0.000 description 11
- 235000014469 Bacillus subtilis Nutrition 0.000 description 10
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 10
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 10
- 244000005700 microbiome Species 0.000 description 10
- 241000588724 Escherichia coli Species 0.000 description 9
- 239000000126 substance Substances 0.000 description 9
- 238000012360 testing method Methods 0.000 description 9
- 244000063299 Bacillus subtilis Species 0.000 description 8
- 230000000052 comparative effect Effects 0.000 description 8
- 241000222120 Candida <Saccharomycetales> Species 0.000 description 7
- 239000004615 ingredient Substances 0.000 description 7
- 239000002609 medium Substances 0.000 description 7
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 6
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 6
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 6
- 230000000694 effects Effects 0.000 description 5
- 238000000605 extraction Methods 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- 238000010992 reflux Methods 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- 241000192125 Firmicutes Species 0.000 description 4
- 208000032843 Hemorrhage Diseases 0.000 description 4
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 4
- 230000032683 aging Effects 0.000 description 4
- 235000009508 confectionery Nutrition 0.000 description 4
- 230000006866 deterioration Effects 0.000 description 4
- 230000002401 inhibitory effect Effects 0.000 description 4
- VVOAZFWZEDHOOU-UHFFFAOYSA-N magnolol Chemical compound OC1=CC=C(CC=C)C=C1C1=CC(CC=C)=CC=C1O VVOAZFWZEDHOOU-UHFFFAOYSA-N 0.000 description 4
- 239000008213 purified water Substances 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- 241001494479 Pecora Species 0.000 description 3
- 240000000275 Persicaria hydropiper Species 0.000 description 3
- 235000017337 Persicaria hydropiper Nutrition 0.000 description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
- 230000001580 bacterial effect Effects 0.000 description 3
- 208000034158 bleeding Diseases 0.000 description 3
- 230000000740 bleeding effect Effects 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 208000001780 epistaxis Diseases 0.000 description 3
- 235000011187 glycerol Nutrition 0.000 description 3
- 230000002147 killing effect Effects 0.000 description 3
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 3
- 230000000813 microbial effect Effects 0.000 description 3
- 230000000144 pharmacologic effect Effects 0.000 description 3
- 238000004321 preservation Methods 0.000 description 3
- 239000000523 sample Substances 0.000 description 3
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 241000222122 Candida albicans Species 0.000 description 2
- 244000037364 Cinnamomum aromaticum Species 0.000 description 2
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 241000901842 Escherichia coli W Species 0.000 description 2
- 241000233866 Fungi Species 0.000 description 2
- 206010019233 Headaches Diseases 0.000 description 2
- 241000480567 Pseudomonas aeruginosa C Species 0.000 description 2
- 206010040880 Skin irritation Diseases 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000002141 anti-parasite Effects 0.000 description 2
- 238000002802 antimicrobial activity assay Methods 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- FUWUEFKEXZQKKA-UHFFFAOYSA-N beta-thujaplicin Chemical compound CC(C)C=1C=CC=C(O)C(=O)C=1 FUWUEFKEXZQKKA-UHFFFAOYSA-N 0.000 description 2
- 229940095731 candida albicans Drugs 0.000 description 2
- 239000003990 capacitor Substances 0.000 description 2
- 239000012141 concentrate Substances 0.000 description 2
- 238000011109 contamination Methods 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 208000002173 dizziness Diseases 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- 231100000869 headache Toxicity 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 208000014617 hemorrhoid Diseases 0.000 description 2
- 241000411851 herbal medicine Species 0.000 description 2
- 238000011081 inoculation Methods 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 2
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 2
- 229960002216 methylparaben Drugs 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 229930014626 natural product Natural products 0.000 description 2
- 239000000575 pesticide Substances 0.000 description 2
- 239000003208 petroleum Substances 0.000 description 2
- 229960005323 phenoxyethanol Drugs 0.000 description 2
- 230000001766 physiological effect Effects 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 2
- 230000036556 skin irritation Effects 0.000 description 2
- 231100000475 skin irritation Toxicity 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 235000018553 tannin Nutrition 0.000 description 2
- 229920001864 tannin Polymers 0.000 description 2
- 239000001648 tannin Substances 0.000 description 2
- KJPRLNWUNMBNBZ-QPJJXVBHSA-N (E)-cinnamaldehyde Chemical compound O=C\C=C\C1=CC=CC=C1 KJPRLNWUNMBNBZ-QPJJXVBHSA-N 0.000 description 1
- VNPMDUDIDCXVCH-UHFFFAOYSA-N 2-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]-3-(3-piperazin-1-ylpropyl)pyrazol-1-yl]-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound O=C(CN1C=C(C(CCCN2CCNCC2)=N1)C1=CN=C(NC2CC3=C(C2)C=CC=C3)N=C1)N1CCC2=C(C1)N=NN2 VNPMDUDIDCXVCH-UHFFFAOYSA-N 0.000 description 1
- XXZCIYUJYUESMD-UHFFFAOYSA-N 2-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]-3-(morpholin-4-ylmethyl)pyrazol-1-yl]-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C=1C(=NN(C=1)CC(=O)N1CC2=C(CC1)NN=N2)CN1CCOCC1 XXZCIYUJYUESMD-UHFFFAOYSA-N 0.000 description 1
- LPZOCVVDSHQFST-UHFFFAOYSA-N 2-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]-3-ethylpyrazol-1-yl]-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C=1C(=NN(C=1)CC(=O)N1CC2=C(CC1)NN=N2)CC LPZOCVVDSHQFST-UHFFFAOYSA-N 0.000 description 1
- HVTQDSGGHBWVTR-UHFFFAOYSA-N 2-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]-3-phenylmethoxypyrazol-1-yl]-1-morpholin-4-ylethanone Chemical compound C(C1=CC=CC=C1)OC1=NN(C=C1C=1C=NC(=NC=1)NC1CC2=CC=CC=C2C1)CC(=O)N1CCOCC1 HVTQDSGGHBWVTR-UHFFFAOYSA-N 0.000 description 1
- YJLUBHOZZTYQIP-UHFFFAOYSA-N 2-[5-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]-1,3,4-oxadiazol-2-yl]-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C1=NN=C(O1)CC(=O)N1CC2=C(CC1)NN=N2 YJLUBHOZZTYQIP-UHFFFAOYSA-N 0.000 description 1
- APLNAFMUEHKRLM-UHFFFAOYSA-N 2-[5-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]-1,3,4-oxadiazol-2-yl]-1-(3,4,6,7-tetrahydroimidazo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C1=NN=C(O1)CC(=O)N1CC2=C(CC1)N=CN2 APLNAFMUEHKRLM-UHFFFAOYSA-N 0.000 description 1
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 1
- QGJZLNKBHJESQX-UHFFFAOYSA-N 3-Epi-Betulin-Saeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C(=C)C)C5C4CCC3C21C QGJZLNKBHJESQX-UHFFFAOYSA-N 0.000 description 1
- CLOUCVRNYSHRCF-UHFFFAOYSA-N 3beta-Hydroxy-20(29)-Lupen-3,27-oic acid Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C(O)=O)CCC5(C)CCC(C(=C)C)C5C4CCC3C21C CLOUCVRNYSHRCF-UHFFFAOYSA-N 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N 4-hydroxybenzoic acid Chemical compound OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- CONKBQPVFMXDOV-QHCPKHFHSA-N 6-[(5S)-5-[[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]methyl]-2-oxo-1,3-oxazolidin-3-yl]-3H-1,3-benzoxazol-2-one Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)N1CCN(CC1)C[C@H]1CN(C(O1)=O)C1=CC2=C(NC(O2)=O)C=C1 CONKBQPVFMXDOV-QHCPKHFHSA-N 0.000 description 1
- 240000000643 Alnus japonica Species 0.000 description 1
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- 235000018185 Betula X alpestris Nutrition 0.000 description 1
- 235000018212 Betula X uliginosa Nutrition 0.000 description 1
- DIZWSDNSTNAYHK-XGWVBXMLSA-N Betulinic acid Natural products CC(=C)[C@@H]1C[C@H]([C@H]2CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@@]34C)[C@@H]12)C(=O)O DIZWSDNSTNAYHK-XGWVBXMLSA-N 0.000 description 1
- 206010006326 Breath odour Diseases 0.000 description 1
- 241000723347 Cinnamomum Species 0.000 description 1
- 240000000560 Citrus x paradisi Species 0.000 description 1
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical compound [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 description 1
- 241000393483 Dryopteris crassirhizoma Species 0.000 description 1
- 206010061459 Gastrointestinal ulcer Diseases 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 238000002768 Kirby-Bauer method Methods 0.000 description 1
- 235000019687 Lamb Nutrition 0.000 description 1
- 241000218378 Magnolia Species 0.000 description 1
- 235000016791 Nymphaea odorata subsp odorata Nutrition 0.000 description 1
- 241000209477 Nymphaeaceae Species 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 244000061458 Solanum melongena Species 0.000 description 1
- 235000002597 Solanum melongena Nutrition 0.000 description 1
- 206010053476 Traumatic haemorrhage Diseases 0.000 description 1
- AXMVYSVVTMKQSL-UHFFFAOYSA-N UNPD142122 Natural products OC1=CC=C(C=CC=O)C=C1O AXMVYSVVTMKQSL-UHFFFAOYSA-N 0.000 description 1
- 206010046788 Uterine haemorrhage Diseases 0.000 description 1
- 229960001138 acetylsalicylic acid Drugs 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- TUFYVOCKVJOUIR-UHFFFAOYSA-N alpha-Thujaplicin Natural products CC(C)C=1C=CC=CC(=O)C=1O TUFYVOCKVJOUIR-UHFFFAOYSA-N 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000000767 anti-ulcer Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 239000003096 antiparasitic agent Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 150000001491 aromatic compounds Chemical class 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 229960004365 benzoic acid Drugs 0.000 description 1
- QGJZLNKBHJESQX-FZFNOLFKSA-N betulinic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C(=C)C)[C@@H]5[C@H]4CC[C@@H]3[C@]21C QGJZLNKBHJESQX-FZFNOLFKSA-N 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 229940081733 cetearyl alcohol Drugs 0.000 description 1
- 229940112822 chewing gum Drugs 0.000 description 1
- 235000015218 chewing gum Nutrition 0.000 description 1
- KJPRLNWUNMBNBZ-UHFFFAOYSA-N cinnamic aldehyde Natural products O=CC=CC1=CC=CC=C1 KJPRLNWUNMBNBZ-UHFFFAOYSA-N 0.000 description 1
- 229940117916 cinnamic aldehyde Drugs 0.000 description 1
- 230000005757 colony formation Effects 0.000 description 1
- 230000004154 complement system Effects 0.000 description 1
- 230000009133 cooperative interaction Effects 0.000 description 1
- 239000007857 degradation product Substances 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- PZXJOHSZQAEJFE-UHFFFAOYSA-N dihydrobetulinic acid Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C(C)C)C5C4CCC3C21C PZXJOHSZQAEJFE-UHFFFAOYSA-N 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000004945 emulsification Methods 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 230000002550 fecal effect Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- XTLWNMXYCHABQH-UHFFFAOYSA-N germanicol Natural products CC1(C)CCC2(C)CCC3(C)C(CCC4(C)C5(C)CCC(O)C(C)(C)C5CCC34C)C2=C1 XTLWNMXYCHABQH-UHFFFAOYSA-N 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- -1 household goods Substances 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 150000002576 ketones Chemical group 0.000 description 1
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 description 1
- 239000003094 microcapsule Substances 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 239000002088 nanocapsule Substances 0.000 description 1
- 208000011309 nasal bleeding Diseases 0.000 description 1
- 239000005445 natural material Substances 0.000 description 1
- MQYXUWHLBZFQQO-UHFFFAOYSA-N nepehinol Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C)CCC(C(=C)C)C5C4CCC3C21C MQYXUWHLBZFQQO-UHFFFAOYSA-N 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- ORJVQPIHKOARKV-OAHLLOKOSA-N nuciferine Chemical compound C1C2=CC=CC=C2C2=C(OC)C(OC)=CC3=C2[C@@H]1N(C)CC3 ORJVQPIHKOARKV-OAHLLOKOSA-N 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 1
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 230000003071 parasitic effect Effects 0.000 description 1
- 230000032696 parturition Effects 0.000 description 1
- QCDYQQDYXPDABM-UHFFFAOYSA-N phloroglucinol Chemical group OC1=CC(O)=CC(O)=C1 QCDYQQDYXPDABM-UHFFFAOYSA-N 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 238000011533 pre-incubation Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 229940077082 red pepper extract Drugs 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- 235000010199 sorbic acid Nutrition 0.000 description 1
- 239000004334 sorbic acid Substances 0.000 description 1
- 229940075582 sorbic acid Drugs 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 230000000475 sunscreen effect Effects 0.000 description 1
- 239000000516 sunscreening agent Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- GGGUGZHBAOMSFJ-GADYQYKKSA-N taraxerol Chemical compound CC([C@@H]1CC2)(C)[C@@H](O)CC[C@]1(C)[C@@H]1[C@]2(C)C2=CC[C@@]3(C)CCC(C)(C)C[C@H]3[C@]2(C)CC1 GGGUGZHBAOMSFJ-GADYQYKKSA-N 0.000 description 1
- HYTFUKZLSYXRDX-UHFFFAOYSA-N taraxerol Natural products CC1CCCC2C3(C)CCC4(C)C5CC(C)(C)CCC5(C)C=CC4(C)C3C(O)CC12C HYTFUKZLSYXRDX-UHFFFAOYSA-N 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 239000000606 toothpaste Substances 0.000 description 1
- 229940034610 toothpaste Drugs 0.000 description 1
- LADGBHLMCUINGV-UHFFFAOYSA-N tricaprin Chemical compound CCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCC)COC(=O)CCCCCCCCC LADGBHLMCUINGV-UHFFFAOYSA-N 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930007845 β-thujaplicin Natural products 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/005—Antimicrobial preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Dermatology (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Cosmetics (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Abstract
본 발명은 관중추출물 0.2 내지 2.0 중량%를 함유하는 추출물을 연잎추출물 0.2 내지 2.0 중량%, 적양추출물 0.1 내지 2.0 중량%, 계피추출물 0.2 내지 2.0 중량%로 이루어진 군중에서 선택되는 1종 이상의 추출물을 혼합하여 복합 천연 항균 및 방부 활성을 가지는 화장료 조성물이다.The present invention is mixed with an extract containing 0.2 to 2.0% by weight of the extract of one or more extracts selected from the group consisting of 0.2 to 2.0% by weight lotus leaf extract, 0.1 to 2.0% by weight red wine extract, 0.2 to 2.0% by weight cinnamon extract It is a cosmetic composition having a composite natural antibacterial and antiseptic activity.
본 발명의 화장료 조성물은 국내산 약용식물을 원료로 하여 추출물을 적절한 비율로 혼합한 것으로서 식물추출물 간의 상호협력 작용에 따른 우수한 항균 활성을 나타내 주어 천연 방부제로서 효과적으로 이용될 수 있다.The cosmetic composition of the present invention is a mixture of extracts in an appropriate ratio using domestic medicinal plants as a raw material and can be effectively used as a natural preservative by showing excellent antimicrobial activity due to the cooperative action between plant extracts.
천연항균제, 천연방부제, 관중, 연잎, 적양, 계피, 화장료 조성물 Natural antibacterial, natural preservative, spectators, lotus leaf, red wine, cinnamon, cosmetic composition
Description
본 발명은 관중추출물, 연잎 추출물, 적양추출물, 계피추출물을 복합적으로 사용하여 천연 복합추출물 제조하는 방법 및 이를 이용한 천연 항균, 방부제 조성물에 관한 것이다. The present invention relates to a method for producing a natural complex extract using a composite extract, lotus leaf extract, red pepper extract, cinnamon extract and a natural antibacterial, preservative composition using the same.
본 발명에서는 화장품 방부제로 기존에 널리 사용되었던 파라벤류의 단점인 자극성을 보완할 수 있는 천연물질로부터 방부제를 개발하기 위하여 관중추출물을 포함하고 적양추출물, 연교추출물, 계피추출물을 이용하여 복합적으로 적절한 비율로 혼합하여 추출물 간의 상호 협력 작용에 의해 보다 우수한 항균, 방부능을 갖는 조성물을 기술하고자 한다.In the present invention, in order to develop a preservative from a natural substance that can compensate for the irritation that is a disadvantage of the parabens, which have been widely used as a cosmetic preservative, it contains a spectral extract and a complex ratio appropriately using a red yang extract, a duct extract, a cinnamon extract By mixing with the mutual cooperation between the extracts to describe a composition having a better antibacterial, antiseptic properties.
화장품의 변질 요인은 물리적, 화학적 변화에 의한 요인과 미생물 오염에 의한 요인으로 구별할 수 있다. 이 중에서 미생물 오염 문제는 제품 자체의 변질로 인한 상품 가치의 저하는 물론 피부 사용 부위에 대한 위생학적 측면 때문에 그 중요성에 대한 인식이 높아지고 있다. The deterioration factors of cosmetics can be classified into factors caused by physical and chemical changes and factors caused by microbial contamination. Among them, the problem of microbial contamination is increasing due to the deterioration of the product value due to the deterioration of the product itself as well as the hygienic aspects of the skin use area.
화장품은 천연물에서 유래된 영양성분과 미생물에 의해 분해 되기 쉬운 원료가 많이 사용되고 있는 관계로 유통과정에서 또는 소비자가 사용 중에 곰팡이, 효모, 세균 등의 미생물에 의해 오염되기 쉬우므로, 이와 갚은 미생물 성장을 억제하기 위하여 방부제를 첨가하며, 최소량으로 최대의 항균력을 나타내도록 하여야 한다. 따라서 화장품 제품 중의 영양성분의 배합, pH, 유화형태, 방부제의 혼합사용 및 그 안정성을 고려하여야 함은 물론이고 제품 중의 모든 원료 성분에 대한 항균활성능 및 피부자극 여부를 사전에 미리 파악하여 각 제품별로 적절한 방부체계를 선택하는 것은 매우 중요한 일이다.Since cosmetics use many nutrients derived from natural products and raw materials that are easily decomposed by microorganisms, cosmetics are easily contaminated by microorganisms such as mold, yeast, and bacteria during distribution or consumer use. To prevent this, preservatives should be added and the maximum amount of antimicrobial activity should be shown. Therefore, the formulation, pH, emulsification form, mixed use of preservatives and its stability should be taken into consideration, as well as antimicrobial activity and skin irritation of all ingredients in the product in advance. It is very important to choose an appropriate preservation system.
미생물은 온도, pH 또는 다른 어떤 특수 환경 하에서도 수분이 존재하면 생육할 수 있는 특징이 있다. 따라서 수분활성이 높은 Aw ≥ 0.90의 대부분의 화장품에는 항상 방부제가 필요하다. 화장품의 성분을 보면 미생물이 생육하기에 일반적으로 필요한 요소인 물, 질소원, 무기질, 비타민, 산소, pH 등과 제품의 유통과정에서 적당한 온도에 있음으로 거의가 미생물이 증식하기 쉬운 조건을 갖추고 있다. 따라서 화장품이 미생물로부터 오염되면 오염된 미생물의 이용 성분에 따라 특징적인 현상이 나타난다. 예를 들면, 탄수화물이 분해 되면 산이나 가스가 생성되고 표면에 기포가 생기기도 한다. 한편 유지화합물에서는 지방산이나 케톤(ketone) 잔기가 생성되어 산패가 일어나며, 또한 단백질 및 관련 분해물은 대사되어 이취의 원인이 되기도 한다. 그러므로 이와 같이 화장품은 항시 미생물로부터 오염되기 쉬운 제형으로, 보존상의 문제점을 해결하기 위해서 방부제를 사용한다. 특히, 알코올이 포함되지 않은 제품과 유분이 많은 자외선 차단제품 일수록 더욱 미생물의 증식이 빠르다. 이에 따라 방부제는 안전하고, 안정하며, 값이 싸고, 쉽게 응용할 수 있어야 하며, 제품 내의 성분들과 용기와의 양립성이 우수하여야 한다.Microorganisms are characterized by their ability to grow in the presence of moisture under temperature, pH or any other special environment. Therefore, preservatives are always needed in most cosmetic products having high water activity, Aw ≥ 0.90. When looking at the components of cosmetics, water, nitrogen sources, minerals, vitamins, oxygen, pH, etc., which are generally necessary for the growth of microorganisms, are at a suitable temperature in the distribution process of the product, and thus almost all of them have conditions for easy growth of microorganisms. Therefore, when cosmetics are contaminated from microorganisms, characteristic phenomena appear depending on the components of the contaminated microorganisms. For example, carbohydrates decompose and produce acids or gases and bubbles on their surfaces. Fatty acids and ketone residues are produced by rancids, and protein and related degradation products are metabolized to cause off-flavor. Therefore, the cosmetics are always easy to be contaminated by microorganisms, and use preservatives to solve the preservation problems. In particular, products containing no alcohol and sunscreen products with a lot of oil, the faster the growth of microorganisms. As a result, the preservative must be safe, stable, inexpensive, easily applicable, and have good compatibility with the components in the product and the container.
급격한 산업화로 인한 환경오염과 복잡한 대도시의 생활은 현대인들에게 보다 자연주의적 삶을 동경하게 함에 따라 소비자들의 생활패턴으로 외형적 모습보다 심신의 안정을 통해 삶의 만족도를 높이려는 웰빙 (well-being) 지향 현상이 두드러지게 나타나고 있다. 이에 화장품 산업에서도 화학적 성분을 배제하고 유기농 원료를 사용하여 순 식물성 성분임을 표방하는 자연주의 화장품들이 폭발적 인기를 얻고 있다. 다양한 천연소재를 이용한 화장품의 개발이 이루어져 천연화장품한방화장품의 전성시대가 도래하고 있다. 이런 소비 경향에 따라 ‘천연재료의 무방부제 천연화장품’, ‘인공파라벤이나 합성화학원료 사용 안한’, ‘100% 천연원료’등으로 광고를 하며 시중에 유통되고 있다. 하지만, 이들 몇몇 업체에서 대한 시험 결과, 메칠파라벤, 페녹시에탄올, 소르빈산, 안식향산 등의 방부제가 검출됐을 뿐만 아니라, 세균과 곰팡이까지 검출되는 일이 나타났다. Environmental pollution due to rapid industrialization and life in complex metropolitan cities make modern people admire more naturalistic life. Directional phenomenon is prominent. In the cosmetics industry, naturalist cosmetics, which exclude chemicals and use organic ingredients, claim to be pure vegetable ingredients, are gaining popularity. With the development of cosmetics using various natural materials, the era of the heyday of natural cosmetic herbal cosmetics is coming. According to this consumption trend, it is advertised as 'unnatural preservatives of natural materials', 'no artificial parabens or synthetic chemical raw materials', and '100% natural raw materials'. However, tests at several of these companies showed that preservatives such as methylparaben, phenoxyethanol, sorbic acid, and benzoic acid were detected, as well as bacteria and fungi.
이러한 문제점들로 인하여 제품의 안전성과 경제성이 우수한 천연방부제에 대한 연구가 해결해야할 과제로 남아 있으며, 그 결과로 약용식물 및 해양생물, 곤충, 미생물 등이 만들어 내는 천연 항균성 물질이 보고되었다. 그러나 보고된 천연 항균성물질의 대부분은 색과 이취, 안정성 저하, 좁은 항균스펙트럼, 제형상의 문제점 등으로 인하여 상용화되지 못하고 있으며 편백 추출물인 히노키티올 ( Hinokitiol), 목련추출물인 마그노롤 (Magnolol), 자몽추출물인 DF-100 등 극히 일부만 상용화되고 있는 실정이다.Due to these problems, studies on natural preservatives with excellent safety and economical efficiency of products remain to be solved. As a result, natural antimicrobial substances produced by medicinal plants, marine organisms, insects and microorganisms have been reported. However, most of the reported natural antimicrobial substances are not commercialized due to color, off-flavor, deterioration of stability, narrow antimicrobial spectrum, and formulation problems.They are Hinokitiol, a magnolia extract, Magnolol, Magnolol, and grapefruit. Only a fraction of the extract, such as DF-100 is commercialized.
본 발명의 목적은 관중 추출물, 연잎 추출물, 적양추출물, 계피추출물을 복합적으로 사용하여 천연 복합추출물 제조하는 방법 및 이를 이용한 천연 항균, 방부제 조성물을 제공하는 것이다.An object of the present invention is to provide a method for producing a natural complex extract using a composite extract, lotus leaf extract, red leaf extract, cinnamon extract and a natural antibacterial, preservative composition using the same.
이와 같은 목적을 달성하기 위해 본 발명은 항균 및 방부 활성을 갖는 추출물을 이용한 화장료 조성물에 관한 것으로 관중추출물 0.2 내지 2.0 중량%를 함유하는 추출물을 연잎추출물 0.2 내지 2.0 중량%, 적양추출물 0.1 내지 2.0 중량%, 계피추출물 0.2 내지 2.0 중량%로 이루어진 군중에서 선택되는 1종 이상의 추출물을 혼합하여 복합 천연 항균 및 방부 활성을 가지는 화장료 조성물이다.In order to achieve the above object, the present invention relates to a cosmetic composition using an extract having antibacterial and antiseptic activity, the extract containing 0.2 to 2.0% by weight of the spectral extract, the lotus leaf extract of 0.2 to 2.0% by weight, the red extract 0.1 to 2.0% %, Cinnamon extract is a cosmetic composition having a complex natural antibacterial and antiseptic activity by mixing at least one extract selected from the group consisting of 0.2 to 2.0% by weight.
상기 화장료 조성물은 관중추출물을 함유하고 연잎추출물, 적양추출물, 계피추출물을 적절한 비율로 혼합한 것으로서 추출물 간의 상호협력 작용에 따른 우수한 항균 활성을 나타내 주어 천연 방부제로서 효과적으로 이용될 수 있다.The cosmetic composition contains a spectral extract and lotus leaf extract, red yang extract, cinnamon extract in an appropriate ratio, showing excellent antimicrobial activity according to the interaction between the extract can be effectively used as a natural preservative.
본 발명의 관중은 면마과의 여러해살이 초본식물인 관중 (Dryopteris crassirhizoma Nakai)의 뿌리줄기로, 성미는 쓰고 서늘하며 뿌리는 삐뚤 하게 자라며 굵은 덩어리 모양이고 단단하며 잎자루의 흔적 및 수염뿌리가 많이 있고 수색 또는 짙은 갈색의 큰 비닐이 빽빽하게 있다. 우리나라 거의 전 지역의 비교적 깊은 산지의 나무숲 속 그늘진 습한 땅에서 자란다. 세계적으로 중국, 일본, 러시아에 분포되어 있다. 가을 또는 이른 봄에 뿌리줄기를 캐어 뿌리와 비늘쪽잎을 다듬어 버리고 잎꼭지 밑둥과 함께 가로 또는 세로로 잘라서 햇볕에서 말린다. 뿌리줄기에 필리신이 약 7% 들어 있고, 플라바탄닌계통의 탄닌질(7~10%)과 기름 (5~6%), 플라보노이드 등이 알려졌다. 구충성분은 필리신산과 필리신부타논이 메틸렌을 거쳐서 2~3개 분자가 결합된 플로로글루신 유도체이다. 이 유도체 중에서도 아스피딘, 알바스피딘의 구충효과가 가장 높다. 뿌리의 약리 효과는 구충작용, 항바이러스 작용, 항균작용, 자궁에 대한 작용, 토혈, 코피, 암치질로 인한 변혈, 적리, 대하중에 대한 치료효과 등 다양한 생리 활성을 나타내며 독을 함유하여 임산부, 소아, 소화기관 궤양 환자에게는 좋지 않으나 일반적으로는 위장에서 흡수되지 않아 오랫동안 한약재로 이용되어 왔다.The spectators of the present invention are root stems of a perennial herbaceous plant ( Dryopteris crassirhizoma Nakai), which is a bitter , cool, roots grow crooked , thick lumps, hard, with many traces of petioles and beard roots. There is a big dark brown large vinyl. It grows in shaded wet land in the forest of relatively deep mountainous regions of almost all of Korea. It is distributed in China, Japan, and Russia worldwide. In autumn or early spring, cut the rhizome, trim the roots and scaly leaves, cut them horizontally or vertically with the undersides of the leaves and dry them in the sun. About 7% of the phylysin in the rhizome, flavantannin-based tannins (7-10%), oil (5-6%), flavonoids, etc. are known. The parasitic component is a phloroglucine derivative in which two to three molecules are combined with phylic acid and phylisine butanone via methylene. Among these derivatives, aspirin and albapidine have the highest antiparasitic effect. The pharmacological effects of the roots are various physiological activities such as antiparasitic, antiviral, antibacterial, uterine, hemorrhage, nosebleeds, hemorrhoids, hemostasis, hemorrhoids, and heavy loads. It is not good for patients with gastrointestinal ulcers, but in general, it has not been absorbed from the stomach and has been used as a herbal medicine for a long time.
본 발명의 연잎은 수련과의 여러해살이 수생식물인 연꽃 (Nelumbo nucifera Gaertn.)의 잎 부위로 성미는 달고 떫으며 평범하다. 장수와 건강의 상징일 뿐 아니라, 명예와 영생, 행운을 나타내기도 하는 연의 잎은 인도와 이집트 같은 열대지방이 원산지로 우리나라를 비롯하여 일본, 중국, 시베리아 등 동양의 여러 나라에서 널리 재배한다. 연의 잎에는 로에메린, 누시페린, 놀누시페린 등이 함유되어 있고, 약리작용으로 여름에 설사를 그치게 하고 두통과 어지럼증을 해소시킨다. 또한, 토혈, 코피, 대변출혈, 자궁출혈을 그치게 하고, 산후에 어혈로 인한 어지럼증을 치료하는데 이용되었다.Lotus leaf of the present invention is a perennial aquatic plant of water lilies ( Nelumbo nucifera Gaertn.) Leaf area, with mild, sweet and mediocre taste. As well as a symbol of longevity and health, the leaves of the lotus, which show honor, eternal life, and luck, are native to tropical regions such as India and Egypt, and are widely grown in Korea, Japan, China, and Siberia. The leaves of lotus, Loe Merin, Nuciferin, Nolanciferin, etc., and pharmacological action to stop diarrhea in the summer and to relieve headaches and dizziness. It has also been used to stop bleeding, nosebleeds, fecal bleeding, uterine bleeding, and to treat dizziness caused by bleeding after giving birth.
본 발명의 적양은 자작나무과의 낙엽성 큰키나무인 오리나무 (Alnus japonica Steud.)의 어린 가지와 껍질로 성미는 달고 담담하며 평범하다. 우리나라 북부, 중부, 남부, 제조도의 해발 약 1,000M 아래의 산기슭, 산중턱, 산골짜기 등 에서 자란다. 세계적으로는 중국 (동북), 러시아 (극동), 일본 등에 분포되어 있다. 봄에 껍질을 벗겨 햇볕에서 말리고 이 껍질에는 탄닌질 (5 ~10%), 트리케르페노이드인 타락세롤, 베툴린산 등이 있다. 약리효과는 청열, 강화하는 작용이 있어서 비출혈, 설사, 외상출혈에 쓰였으며, 민간에서는 숙취해소의 목적에 사용되었다. Red sheep of the present invention is a deciduous large tall tree of the birch ( Alnus japonica Steud.) The young eggplant and the bark are sweet, cool, and plain. It grows in the foothills, mountainsides, and valleys below about 1,000m above sea level in northern, central, southern part of Korea. It is distributed worldwide in China (Northeast), Russia (Far East) and Japan. Peel and dry in the sun in the spring, which contains tannins (5-10%), the trikerpenoids taraxerol, and betulinic acid. The pharmacological effect was clearing and strengthening, so it was used for nasal bleeding, diarrhea and traumatic bleeding.
본 발명의 계피는 녹나무과의 상록성 큰키나무인 계수나무 (Cinnamomum cassia Pre니.)의 나무껍질을 건조 시킨 것으로 성미는 맵고 따뜻하다. 한방에서는 두통, 발열, 신경성심계향진, 진통 및 감기 등의 치료에 많이 사용되는 중요한 생약이다. 계피의 주요 성분은 방향족 화합물은 시남알데하이드로 음료, 츄잉껌, 치약, 화장품의 향 성분 및 구취제거제 등으로 이용되고 있다. 계피의 생리활성 작용으로는 항균 효과, 항돌연변이원성, 항암효과, 항궤양유발 작용, 계란의 면역항체 증강 효과, 항알러지 효과 및 보체계 활성화 작용 등의 다양한 연구가 보고 되어 있다.Cinnamon of the present invention is an evergreen big-key tree cassia ( Cinnamomum The dried bark of cassia Preni .), temper is hot and warm. In Chinese medicine, it is an important herbal medicine that is widely used for the treatment of headache, fever, nervous system, pain, and cold. The main component of cinnamon is an aromatic compound, which is used as cinnamic aldehyde drink, chewing gum, toothpaste, fragrance component of cosmetics, and bad breath remover. Cinnamon's physiological activity has been reported to include antimicrobial effect, antimutagenicity, anticancer effect, anti-ulcer effect, egg's immune antibody enhancement effect, anti-allergic effect and complement system activation.
본 발명의 관중 추출물은 관중을 세절하여 물, 에탄올, 메탄올, 부탄올, 프로파놀, 부틸렌글리콜, 글리세린, 클로로포름, 에틸아세테이트, 디클로로메탄, 헥산, 아세톤, 아세토나이트릴, 페트로레움에테르 및 디에틸에테르로 이루어진 군으로부터 선택된 1종 이상의 용매로 추출한 것이다.The spectral extract of the present invention may be divided into spectral parts of water, ethanol, methanol, butanol, propanol, butylene glycol, glycerin, chloroform, ethyl acetate, dichloromethane, hexane, acetone, acetonitrile, petroleum ether and diethyl ether. It is extracted with one or more solvents selected from the group consisting of.
추출방법은 세절한 관중을 용매 하에 안정적인 온도에서 침지시키거나 냉각콘덴서가 장착된 추출기에서 가온 환류 추출한 후, 여과하여 감압농축하고 감압 농축물을 동결 건조하여 제조된다. 또한, 추출공정 수행 후 저온 숙성 또는 고온 숙 성하는 공정을 포함할 수 있다. Extraction method is prepared by immersing the fine audience at a stable temperature in a solvent or by heating under reflux extraction in an extractor equipped with a cooling capacitor, concentrated by filtration and concentrated under reduced pressure and freeze-dried the concentrated concentrate. In addition, after performing the extraction process may include a low temperature aging or high temperature aging process.
본 발명의 연잎, 적양, 계피 추출물은 연잎, 적양, 계피를 각각 세절하여 물, 에탄올, 메탄올, 부탄올, 프로파놀, 부틸렌글리콜, 글리세린, 클로로포름, 에틸아세테이트, 디클로로메탄, 헥산, 아세톤, 아세토나이트릴, 페트로레움에테르 및 디에틸에테르로 이루어진 군으로부터 선택된 1종 이상의 용매로 추출한 것이다.Lotus leaf, red sheep, cinnamon extract of the present invention is cut into lotus leaf, red sheep, cinnamon, respectively, water, ethanol, methanol, butanol, propanol, butylene glycol, glycerin, chloroform, ethyl acetate, dichloromethane, hexane, acetone, acetonite It is extracted with one or more solvents selected from the group consisting of reel, petroleum ether and diethyl ether.
추출방법은 세절한 연잎, 적양, 계피를 각각 용매 하에 안정적인 온도에서 침지시키거나 냉각콘덴서가 장착된 추출기에서 가온 환류 추출한 후, 여과하여 감압농축하고 감압 농축물을 동결 건조하여 제조된다. 또한, 추출공정 수행 후 저온 숙성 또는 고온 숙성하는 공정을 포함할 수 있다. Extraction method is prepared by immersing the fine lotus leaf, red lamb, cinnamon each in a stable temperature in a solvent or extracted by heating to reflux in an extractor equipped with a cooling capacitor, and then filtered and concentrated under reduced pressure and freeze-dried the concentrated concentrate. In addition, after performing the extraction process may include a low temperature aging or high temperature aging process.
또한 본 발명에 따른 화장료 조성물은 상기의 추출물 외에 본 발명이 목적으로 하는 주 효과를 손상시키지 않고 주 효과에 상승효과를 줄 수 있는 다른 성분 들을 함유하는 것도 무방하다. 상기 관중, 연잎, 적양, 계피 추출물은 조성물 전체에 대하여 동결건조 중량 기준 0.1 내지 10 중량%로 조성물에 존재할 수 있다.In addition, the cosmetic composition according to the present invention may contain other ingredients that can give a synergistic effect to the main effect in addition to the above extract without impairing the main effect of the present invention. The weight, lotus leaf, red leaf, cinnamon extract may be present in the composition in an amount of 0.1 to 10% by weight based on the total lyophilized weight.
만약 상기 식물추출물이 추출물을 함유하는 나노캡슐, 마이크로캡슐, 나노좀등의 제형으로 용액 또는 파우더 형태로 존재한다면 당업자는 상기 농도 범위 내에서 본 발명에 따른 조성물 내에 이 용액 또는 파우더의 양을 조절할 수 있을 것이다. If the plant extract is present in the form of a solution or powder in the form of nanocapsules, microcapsules, nanosomes, etc. containing the extract, those skilled in the art can adjust the amount of the solution or powder in the composition according to the invention within the concentration range There will be.
상기한 바와 같이 광범위한 항균 스펙트럼을 갖는 본 발명에 따른 항균 조성물로 가공된 화장품, 식품, 의약품, 농약, 생활용품 등에 제공된다.It is provided to cosmetics, foods, pharmaceuticals, pesticides, household goods and the like processed with the antimicrobial composition according to the present invention having a broad antimicrobial spectrum as described above.
본 발명의 항균 조성물은 피부외용제로서 그 제형에 있어서 특별히 한정되지 않으며, 유연화장수, 밀크로션, 영양크림, 마사지 크림, 에센스, 클렌징 폼, 클렌징 워터, 팩 또는 보디 오일 등의 기초 화장료 및 파운데이션, 립스틱, 마스카라 또는 메이크업 베이스 등의 색조 화장료 형태로 제조할 수 있다. 본 발명의 화장료를 세정제로 사용할 경우, 세안제 및 목욕제롤 제조할 수 있다.The antimicrobial composition of the present invention is not particularly limited in its formulation as an external preparation for skin, and it is a basic cosmetic and foundation such as softener, milk lotion, nourishing cream, massage cream, essence, cleansing foam, cleansing water, pack or body oil, lipstick It may be prepared in the form of a color cosmetic such as mascara or makeup base. When the cosmetic of the present invention is used as a detergent, a face wash and a bath roll can be prepared.
이하 본 발명을 하기 위해 실시예와 실험예를 통하여 상세하게 설명하나, 이는 본 발명의 이해를 돕기 위하여 제시된 것일 뿐, 본 발명이 이에 한정되는 것은 아니다.Hereinafter, the present invention will be described in detail with reference to Examples and Experimental Examples, which are only presented to aid the understanding of the present invention, but the present invention is not limited thereto.
상기에서 설명한 바와 같이, 본 발명에 따른 항균, 방부제 조성물은 관중추출물 및 연잎추출물, 적양추출물, 계피추출물을 적절한 비율로 혼합하여, 식물추출물 간의 상호협력 작용에 따른 우수한 항균활성을 나타내며, 항균 스펙트럼이 넓어 화장료에 대한 방부 능력이 우수하다.As described above, the antimicrobial and antiseptic composition according to the present invention is mixed with spectral extracts and lotus leaf extracts, red leaf extracts, cinnamon extracts at an appropriate ratio, showing excellent antimicrobial activity due to the cooperative interaction between plant extracts, It is wide and is excellent in preservative ability for cosmetics.
본 발명은 바람직한 실시예에 대해 설명하였으나 당해 기술 분야에서 통상적 지식을 가진 자에 의한 다양한 변형 실시가 가능할 것이며, 이에 변형실시는 본원발명의 보호범위는 특허청구범위에 기재된 바에 따라 보호돼야 할 것이다. 이에 상기 발명된 항균, 방부제 조성물은 화장품뿐만 아니라, 의약, 생활용품, 농약 등의 다양한 분야에서 살균, 항균, 방부목적으로 유용하게 이용가능하다.Although the present invention has been described in terms of the preferred embodiments, various modifications may be made by those skilled in the art, and the modifications should be protected according to the claims. The antimicrobial and antiseptic composition according to the present invention can be usefully used for sterilization, antibacterial and antiseptic purpose in various fields such as medicine, household goods, pesticides as well as cosmetics.
<실시예 1> 관중추출물의 제조 Example 1 Preparation of Spectrum Extracts
건조 중량 200g의 분쇄한 관중을 70% (V/V) 에탄올 수용액으로 6시간 가온 환류추출하고 냉침한 후, 8㎛ 투과사이즈를 갖는 여과지로 여과하였다. 이 여과된 추출액을 60℃이하에서 감압농축한 후 감압건조기를 이용해 완전히 건조시켜 관중 추출물 15.6g을 수득하였다.The dried weight 200g of the crushed tube was heated and refluxed for 6 hours with 70% (V / V) ethanol aqueous solution, and then cooled and filtered through a filter paper having a permeation size of 8 μm. The filtered extract was concentrated under reduced pressure at 60 ° C. or lower and completely dried using a reduced pressure dryer to obtain 15.6 g of the extract in the tube.
<실시예 2> 연잎추출물의 제조 Example 2 Preparation of Lotus Leaf Extract
건조 중량 200g의 분쇄한 연잎을 70% (V/V) 에탄올 수용액으로 6시간 가온 환류추출하고 냉침한 후, 8㎛ 투과사이즈를 갖는 여과지로 여과하였다. 이 여과된 추출액을 60℃이하에서 감압농축한 후 감압건조기를 이용해 완전히 건조시켜 연잎 추출물 17.5g을 수득하였다.The dried lotus leaf having a dry weight of 200 g was heated to reflux for 6 hours with an aqueous 70% (V / V) ethanol solution, and then cooled and filtered. The filtered extract was concentrated under reduced pressure at 60 ° C. or lower, and dried completely using a reduced pressure dryer to obtain 17.5 g of lotus leaf extract.
<< 실시예Example 3> 3> 적양추출물의Red Extract 제조 Produce
건조 중량 200g의 분쇄한 적양을 70% (V/V) 에탄올 수용액으로 6시간 가온 환류추출하고 냉침한 후, 8㎛ 투과사이즈를 갖는 여과지로 여과하였다. 이 여과된 추출액을 60℃이하에서 감압농축한 후 감압건조기를 이용해 완전히 건조시켜 적양 추출물 3.3g을 수득하였다.The dried red ginseng with a dry weight of 200 g was heated to reflux for 6 hours with an aqueous 70% (V / V) ethanol solution, cooled, and then filtered through a filter paper having a permeation size of 8 μm. The filtered extract was concentrated under reduced pressure at 60 ° C. or lower and completely dried using a reduced pressure dryer to obtain 3.3 g of red yang extract.
<< 실시예Example 4> 계피추출물의 제조 4> Preparation of Cinnamon Extract
건조 중량 200g의 분쇄한 계피를 70% (V/V) 에탄올 수용액으로 6시간 가온 환류추출하고 냉침한 후, 8㎛ 투과사이즈를 갖는 여과지로 여과하였다. 이 여과된 추출액을 60℃이하에서 감압농축한 후 감압건조기를 이용해 완전히 건조시켜 계피 추출물 12.3g을 수득하였다.Crushed cinnamon with a dry weight of 200 g was heated to reflux for 6 hours with an aqueous 70% (V / V) ethanol solution and then cooled and filtered through a filter paper having a permeation size of 8 μm. The filtered extract was concentrated under reduced pressure at 60 ° C. or lower and completely dried using a vacuum dryer to obtain 12.3 g of cinnamon extract.
<< 실험예Experimental Example 1> 항균활성 검정 1> Antimicrobial Activity Assay
상기 추출물들의 항균 활성 스펙트럼을 조사하기 위해 원판 확산법 (Kirby- Bauer method)를 이용하였다. 사용한 균주로는 그람양성균으로 고초균 (Bacillus subtilis ATCC 6633), 황색포도상구균 (Staphylococcus aureus ATCC 6538), 그람음성균으로 대장균 (Escherichia coli ATCC 9637), 녹농균 (Pseudomonas aeruginosa ATCC 9027), 효모로는 캔디다 효모 (Candida albicans ATCC 10231)을 한국생명공학연구원 생물자원센터에서 분양 받아 사용하였다.In order to investigate the antimicrobial activity spectrum of the extracts was used the plate diffusion method (Kirby- Bauer method). The strains used were Gram-positive bacteria (Bacillus subtilis ATCC 6633), Staphylococcus aureus ATCC 6538, Gram-negative bacteria (Escherichia coli ATCC 9637), Pseudomonas aeruginosa ATCC 9027, Yeast (Candy) Candida albicans ATCC 10231) was used by the Korea Institute of Bioscience and Biotechnology.
세균은 레신 액체 배지 (Letheen broth)를 사용하였고 배지에 균을 접종하여 37℃ 진탕 배양기에서 24시간 동안 접종 배양하여 사용하였다. 효모는 와이엠 액체 배지 (YM Broth)를 사용하였고 배지에 균을 접종하여 25℃ 진탕 배양기에서 2일간 전배양하여 사용하였다. Bacteria were used as Lesine broth, inoculated with the bacteria, and inoculated and cultured at 37 ° C. incubator for 24 hours. Yeast was used YM Broth (YM Broth) and inoculated with the culture medium was used for two days pre-culture in a 25 ℃ shaking incubator.
보다 구체적인 항균시험은 먼저 세균의 경우, 레신 액체 배지 (Letheen broth)에 균을 접종하여 37℃에서 24시간 전배양하여 준비하고, 효모의 경우, 와이엠 액체 배지 (YM broth)에 균을 접종하여 25℃에서 2일간 전배양한 후, 멸균된 식염수에 희석하여 세균은 약 1× 106 CFU의 균 농도로 각각의 한천평판배지에 도말하고 효모는 약 1× 105 CFU의 균 농도로 한천평판배지에 도말한다. 그 위에 각각의 추출물을 1% 농도로 50㎕ 흡수시킨 멸균된 8mm 페이퍼 디스크 (paper disc)를 얹고 살짝 눌러주어 밀착시킨다. 그 다음, 세균은 37℃에서 24시간 동안 배양하고 효모는 25℃에서 2일간 배양한 후 디스크 주위의 투명대 (clear zone)의 크기 (mm)를 측정하여 비교하였다. For more specific antimicrobial test, inoculate bacteria in Lesinen broth, pre-culture at 37 ℃ for 24 hours, and inoculate bacteria in YM broth in yeast. After 2 days pre-incubation at 25 ° C, the cells were diluted in sterile saline solution and the bacteria were spread on each agar plate medium at a germ concentration of about 1 × 10 6 CFU, and the yeast was agar plated at a germ concentration of about 1 × 10 5 CFU. Smear on the medium. Place a sterile 8mm paper disc on which 50 μl of each extract was absorbed at a concentration of 1%, and gently press the extract. Then, bacteria were incubated at 37 ° C. for 24 hours and yeast were incubated at 25 ° C. for 2 days, and then compared by measuring the size of the clear zone around the disc (mm).
상기 표 1에서 보는 바와 같이 관중추출물의 경우, 그람 양성균인 고초균, 황색포도상구균에 우수한 항균활성을 나타냈으며, 또한 그람 음성균인 대장균, 녹농균 그리고 캔디다 효모에 대해서도 우수한 항균활성을 나타내었다. 연잎추출물의 경우, 고초균, 황색포도상구균 그리고 캔디다 효모에 대해서만 우수한 항균활성을 나타내었으나, 대장균과 녹농균에 대해서는 항균활성 범위가 관찰되지 않았다. 적양추출물의 경우, 황색포도상구균, 대장균 그리고 녹농균에 대해서만 우수한 항균활성을 나타내었고, 계피추출물의 경우에는 고초균, 황색포도상구균, 대장균, 녹농균, 캔디다 효모 등 모든 균에 대해 우수한 항균 활성을 확인할 수 있었다.As shown in Table 1, the spectral extract showed excellent antimicrobial activity against Gram-positive bacteria, Bacillus subtilis, Staphylococcus aureus, and also against Gram-negative bacteria Escherichia coli, Pseudomonas aeruginosa and Candida yeast. Lotus leaf extract showed good antimicrobial activity against Bacillus subtilis, Staphylococcus aureus and Candida yeast, but no range of antimicrobial activity was observed for Escherichia coli and Pseudomonas aeruginosa. Red extracts showed excellent antimicrobial activity against Staphylococcus aureus, Escherichia coli and Pseudomonas aeruginosa, and cinnamon extract showed excellent antibacterial activity against Bacillus subtilis, Staphylococcus aureus, Escherichia coli, Pseudomonas aeruginosa and Candida yeast. .
<< 실험예Experimental Example 2> 항균력 시험 2> antibacterial test
상기 추출물들의 항균력을 평가하기 위하여 농도별로 저해력을 측정하여 최소저해농도를 확인하였다. 사용한 균주로는 항균활성 검정시에 사용한 균주이고 균주마다 배양준비과정은 상기 방법과 동일하다.In order to evaluate the antimicrobial activity of the extracts by determining the inhibitory power by concentration to determine the minimum inhibitory concentration. The strains used were strains used for the antimicrobial activity assay and the preparation procedure for each strain was the same as the above method.
보다 구체적으로는 시험하고자 하는 각 추출물 별로 5% Dimethylsulfoxide (DMSO) 생리식염수용액에 적절한 농도로 희석한 각각 추출물을 멸균된 페트리접시에 2ml 씩 넣고 , 대조군으로 5% Dimethylsulfoxide 생리식염수용액 2 ml을 넣은 후, 각 페트리접시에 멸균 후 50℃로 유지시킨 레신 한천 배지 (Letheen agar) 및 와이엠 한천 배지 (YM agar)를 시료용액과 9:1 비율로 18ml씩 첨가하여 잘 섞은 후 정치하여 응고시킨다.More specifically, 2 ml of each extract, diluted to an appropriate concentration in 5% Dimethylsulfoxide (DMSO) saline solution for each test to be tested, was added to a sterile petri dish, and 2 ml of 5% Dimethylsulfoxide saline solution was used as a control. After sterilization in each Petri dish, Lesinen agar medium (Letheen agar) and YM agar medium (YM agar), which were maintained at 50 ° C., were added to the sample solution in a ratio of 9: 1 by 18 ml, mixed well, and left to solidify.
배지가 고형화되면 전배양시킨 각각의 시험균을 세균의 경우, 최종농도가 약 1~5 × 106 CFU의 균 농도로 각각의 페트리접시에 접종하고 효모의 경우, 1~5 × 105 CFU의 균 농도로 각각의 페트리접시에 접종한다. 각각의 페트리접시는 세균은 37℃, 효모는 25℃에서 1 ~ 5일 배양한 후 육안으로 집락형성 여부를 관찰한다. 균의 생육이 억제되는 평판의 최소 항균제 농도를 최소저해농도 (MIC, Minimum inhibitory concentration)로 한다.Once the medium has solidified, each of the precultivated test bacteria is inoculated into each petri dish at a final concentration of approximately 1 to 5 × 10 6 CFU for bacteria and 1 to 5 × 10 5 CFU for yeast. Inoculate each Petri dish at a bacterial concentration. Each petri dish was cultured at 37 ° C. and yeast at 25 ° C. for 1 to 5 days, and then visually observed colony formation. The minimum inhibitory concentration (MIC) is the minimum concentration of the antimicrobial agent on the plate that inhibits the growth of bacteria.
상기 표 2에서 보는 바와 같이 관중추출물의 경우, 그람 양성균인 고초균과 황색포도상구균에 대해 0.5중량% 이하의 농도에서도 우수한 항균활성을 나타내었으나, 녹농균에 대해서는 상대적으로 약한 항균활성을 나타냈으며, 또한 대장균과 캔디다 효모에 대해서도 매우 약한 항균활성을 나타내었다.As shown in Table 2, the spectral extract showed excellent antimicrobial activity even at concentrations of 0.5% by weight or less against Gram-positive bacteria such as Bacillus subtilis and Staphylococcus aureus, but also showed relatively weak antimicrobial activity against Pseudomonas aeruginosa. It also showed very weak antimicrobial activity against yeast and Candida yeast.
연잎추출물의 경우, 고초균과 황색포도상구균에 대해서는 0.25 중량% 이하의 농도에서 우수한 항균활성을 나타내었으나 캔디다 효모에 대해서는 상대적으로 약한 항균활성을 나타내었으며, 또한 대장균과 녹농균에 대해서도 매우 약한 항균활성을 나타내었다. 적양추출물의 경우, 황색포도상구균에 대해서는 0.25중량% 이하의 농도에서도 우수한 항균활성을 나타내었으나 고초균과 녹농균에 대해서는 상대적으로 약한 항균활성을 나타내었으며, 또한 대장균과 캔디다 효모에 대해서도 매우 약한 항균활성을 나타내었다. 계피추출물의 경우, 고초균과 황색포도상구균에 대해 0.5중량% 이하의 농도에서도 우수한 항균활성을 나타내었으나, 대장균과 캔디다 효모에 대해서는 상대적으로 약한 항균활성을 나타냈으며, 또한 녹농균에 대해서도 매우 약한 항균활성을 나타남을 확인할 수 있었다.Lotus leaf extract showed excellent antimicrobial activity against subtilis of Staphylococcus aureus and Staphylococcus aureus at a concentration of 0.25% by weight or less, but showed relatively weak antimicrobial activity against Candida yeast and very weak antibacterial activity against Escherichia coli and Pseudomonas aeruginosa. It was. In the case of red yang extract, it showed excellent antibacterial activity at concentrations of 0.25% by weight or less against Staphylococcus aureus, but relatively weak antibacterial activity against Bacillus subtilis and Pseudomonas aeruginosa, and also very weak against E. coli and Candida yeast. It was. Cinnamon extract showed good antimicrobial activity at concentrations below 0.5% by weight against Bacillus subtilis and Staphylococcus aureus, but relatively weak against E. coli and Candida yeast and very weak against Pseudomonas aeruginosa. Appeared.
<< 실험예Experimental Example 3> 3> 에멀젼emulsion 베이스 제조 Base manufacturer
상기 추출물을 함유한 화장료 및 기존 화학 방부제를 포함한 에멀젼 베이스를 제조하였다. 실험에 사용된 화장료는 유화형 화장액 형태이고, 그 조성은 표에 나타낸 바와 같다. 우선 표에 기록되어 있는 식물 추출물 또는 화학 방부제를 중량별로 첨가한 후 가)상을 가열하여 90℃로 유지하고 정제수(30%)를 90℃까지 가열한 후 가) 수상 중에 천천히 첨가하여 호모믹서로 균일하게 유화한다. 그 후 실온까지 냉각하고 남은 나)상의 정제수를 첨가하고 균일하게 교반하여 화장액을 제조하였다.An emulsion base containing the cosmetic containing the extract and a conventional chemical preservative was prepared. The cosmetics used in the experiments are in the form of emulsified cosmetic liquids, the composition of which is shown in the table. First, add the plant extracts or chemical preservatives listed in the table by weight, and then a) heat the phase to keep it at 90 ° C, and add purified water (30%) to 90 ° C, and slowly add it in the water phase. Emulsify uniformly. After cooling to room temperature, the remaining b) purified water was added and stirred uniformly to prepare a cosmetic liquid.
<< 실시예Example 5 내지 10> 항균 활성 추출물을 함유한 5 to 10> containing antimicrobial active extract 에멀젼emulsion 베이스의 제조 Manufacture of base
실험예 3의 방법으로 표 4의 조성에 따라 실시예 5 내지 10의 상기 추출물 첨가량을 함유한 에멀젼 베이스를 제조하였다. According to the composition of Table 4 by the method of Experimental Example 3 was prepared an emulsion base containing the added amount of the extract of Examples 5 to 10.
<< 실시예Example 11 내지 14> 항균 활성 추출물을 함유한 11 to 14> containing antimicrobial active extracts 에멀젼emulsion 베이스의 제조 Manufacture of base
실험예 3의 방법으로 표 5의 조성에 따라 실시예 11 내지 14의 상기 추출물 첨가량을 함유한 에멀젼 베이스를 제조하였다. According to the composition of Table 5 by the method of Experimental Example 3 was prepared an emulsion base containing the added amount of the extract of Examples 11-14.
<< 비교예Comparative example 1 내지 2> 1 to 2> 에멀젼emulsion 베이스의 제조 Manufacture of base
실험예 3의 방법으로 표 5의 조성에 따라 화학 방부제를 함유한 비교예 1과 화학방부제 및 상기 추출물을 함유하지 않은 비교예 2의 에멀젼 베이스를 제조하였다.According to the composition of Table 5, the emulsion base of Comparative Example 1 containing a chemical preservative and Comparative Example 2 containing no chemical preservative and the extract was prepared by the method of Experimental Example 3.
<< 실험예Experimental Example 4> 제형 내 4> in formulation 방부력Antiseptic 실험 Experiment
상기 추출물을 함유한 제형 내 방부력을 알아보기 위해, 실시예 5 내지 14, 비교예 1, 비교예 2에서 제조한 에멀젼 베이스의 방부활성 확인 시험을 수행하였다. 방부제 유효성 테스트는 소비자에게 피부 자극을 일으키지 않고 제품을 안전하게 보존하는데 필요로 하는 방부제의 최소농도를 찾기 위한 이유로 제품의 안전성과 소비자 수용에 있어 중요하다. 화장품의 방부력을 측정하는 방법으로 유에스피(USP)와 씨티에프에이(CTFA)의 방법을 많이 사용한다. 본 시험 방법은 미국화장품공업협회 (Cosmetic, Toiletry, and Fragrance Association, 이하 CTFA)의 미생물 가이드라인의 시험법을 사용하였다. In order to determine the antiseptic force in the formulation containing the extract, an antiseptic activity test of the emulsion base prepared in Examples 5 to 14, Comparative Example 1 and Comparative Example 2 was performed. Preservative effectiveness testing is important for product safety and consumer acceptance as it seeks to find the minimum concentration of preservatives needed to safely preserve the product without causing skin irritation to the consumer. To measure the preservation of cosmetics, USP and CFA are widely used. This test method used the microbial guidelines of the Cosmetic, Toiletry, and Fragrance Association (CTFA).
사용한 균주로는 그람양성균으로 고초균 (Bacillus subtilis ATCC 6633), 황색포도상구균 (Staphylococcus aureus ATCC 6538), 그람음성균으로 대장균 (Escherichia coli ATCC 9637), 녹농균 (Pseudomonas aeruginosa ATCC 9027), 효모로는 캔디다 효모 (Candida albicans ATCC 10231)을 사용하였다. 레신 한천배지 (Letheen agar)에는 세균 4종을 접종하고, 와이엠 한천배지 (YM agar)에는 효모를 접종하였다. 세균은 37℃, 효모는 25℃의 배양조에서 각각 24시간 내지 72시간 배양한 후, 0.8% 생리 식염수로 현탁하여 세균은 약 1× 106 CFU, 효모는 1× 105 CFU가 되도록 하였다. 실시예 5 내지 14, 비교예 1 내지 2의 각각 에멀젼 베이스 시료 10g에 세균 4종 혼합현탁액과 효모 1종을 각각 100㎕씩 접종한다. 이 후, 접종된 각각의 시료는 실온에서 보관하며, 1일, 2일, 3일, 7일, 14일 21일, 28일 경과 시마다 무균 조작 하에서 시료 1g을 채취하여 희석액으로 적절히 희석하고 세균은 레신 한천 배지 (Letheen agar), 효모는 와이엠 한천 배지 (YM agar)에 깔아 각각 37℃, 25℃에서 24 내지 72시간 배양 후 계수 하였다. 방부력 유효성으로 세균은 접종 7일 이내 99.9% 이상 균수가 감소해야 하며, 시험기간 동안 증식이 없어야 한다. 또한 효모 , 곰팡이는 접종 7일 이내 최소 90% 이상 균수가 감소해야 하며, 시험 기간 동안 증식하지 않아야 한다. 그 결과를 표 6내지 7과 도 1내지 2에 나타내었다.The strains used were Gram-positive bacteria (Bacillus subtilis ATCC 6633), Staphylococcus aureus ATCC 6538, Gram-negative bacteria (Escherichia coli ATCC 9637), Pseudomonas aeruginosa ATCC 9027, Yeast (Candy) Candida albicans ATCC 10231) was used. Letheen agar was inoculated with four kinds of bacteria, and YM agar was inoculated with yeast. Bacteria were incubated at 37 ° C. and yeast at 25 ° C. for 24 to 72 hours, respectively, and then suspended in 0.8% physiological saline to make bacteria 1 × 10 6 CFU and yeast 1 × 10 5 CFU. 10 g of each emulsion base sample of Examples 5 to 14 and Comparative Examples 1 to 2 were inoculated with 100 µl of four bacterial suspensions and one yeast. Afterwards, each inoculated sample is stored at room temperature, and 1 g of sample is collected under sterile operation every 1 day, 2 days, 3 days, 7 days, 14 days, 21 days and 28 days, and diluted with dilution. Resin agar medium (Letheen agar), yeast was placed on YM agar medium (YM agar) and counted after incubation at 37 ℃, 25 ℃ for 24 to 72 hours. As an antiseptic effect, bacteria should be reduced by more than 99.9% of bacteria within 7 days of inoculation and should not grow during the test period. In addition, yeast and mold should be reduced by at least 90% of bacteria within 7 days of inoculation and should not grow during the test period. The results are shown in Tables 6 to 7 and FIGS.
상기 표 6에 나타난 바와 같이 에멀젼 베이스 제형으로 제조한 실시예 5-10에서는 세균류 사멸에 있어 매우 약한 매우 약한 방부활성을 가지는 것으로 나타났으나, 실시예 13, 14에서는 상대적으로 7일 경과 후에는 모두 사멸시켜 적절한 방부활성을 가지고 있는 것으로 확인되어 관중추출물 및 연잎추출물, 계피추출물이 상호 협력 작용에 의해 방부력이 우수해 진 것으로 판단된다.As shown in Table 6, in Example 5-10 prepared as an emulsion base formulation, it was found to have very weak antiseptic activity in killing bacteria, but in Examples 13 and 14, all after 7 days It was confirmed to have proper antiseptic activity by killing, and the spectral extract, lotus leaf extract, and cinnamon extract were judged to have excellent antiseptic ability by mutual cooperation.
상기 표 7에 나타난 바와 같이 에멀젼 베이스 제형으로 제조한 실시예 5-10에서는 진균류 사멸에 있어 매우 약한 매우 약한 방부활성을 가지는 것으로 나타났으나, 실시예 11, 13, 14에서는 상대적으로 14일 경과 후에는 모두 사멸시켜 표 6의 세균류에 대한 방부력과 유사한 성향으로 적절한 방부력 결과를 보였다. As shown in Table 7, in Example 5-10 prepared as an emulsion base formulation, it was shown to have very weak antiseptic activity in killing fungi, but in Examples 11, 13, and 14 after 14 days All were killed and showed similar preservative results with the same propensity as the preservative against bacteria of Table 6.
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020080022266A KR100986249B1 (en) | 2008-03-11 | 2008-03-11 | Spectrum extract and natural antibacterial and antiseptic composition using the same. |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020080022266A KR100986249B1 (en) | 2008-03-11 | 2008-03-11 | Spectrum extract and natural antibacterial and antiseptic composition using the same. |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20080028391A KR20080028391A (en) | 2008-03-31 |
KR100986249B1 true KR100986249B1 (en) | 2010-10-07 |
Family
ID=39414868
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020080022266A KR100986249B1 (en) | 2008-03-11 | 2008-03-11 | Spectrum extract and natural antibacterial and antiseptic composition using the same. |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR100986249B1 (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101062660B1 (en) | 2008-10-10 | 2011-09-06 | 주식회사 에버코스 | Cosmetic composition comprising a preservative substitute |
KR101393008B1 (en) | 2012-09-06 | 2014-05-12 | 주식회사 코리아나화장품 | Skin external application containing compounds from extract of Dryopteris crassirhizoma with anti bacterial activity |
KR20170025541A (en) | 2015-08-28 | 2017-03-08 | 부경대학교 산학협력단 | An antibacterial composition comprising the extract or fraction of Sargassum serratifolium |
KR20190142932A (en) | 2018-06-19 | 2019-12-30 | 대한민국(농촌진흥청장) | Mask pack composition comprising for moisturizing effect and enhancing elasticity on the skin |
KR20220115447A (en) | 2021-02-10 | 2022-08-17 | 서울대학교산학협력단 | Antiviral agent with inhibitory activitity on SARS-coronavirus-2 by phloroglucinol compounds from Dryopteris crassirhiza and compositions for treatment and prevention of COVID-19 containing the same as an active ingredient |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101716571B1 (en) * | 2015-06-19 | 2017-03-15 | 단국대학교 천안캠퍼스 산학협력단 | Pharmaceutical Composition for Prevention or Treatment of Alzheimer's disease |
KR102269881B1 (en) * | 2018-03-14 | 2021-06-29 | 정연옥 | Composition with antimicrobial or antifungal activity comprising dryopteris crassirhizoma nakai extract, salvia miltiorrhiza bunge extract and scutellaria baicalensis extract and method for preaparing the same |
CN111281829B (en) * | 2020-02-13 | 2022-04-19 | 广东省禾基生物科技有限公司 | Composition containing purslane extract and preparation method and application thereof |
KR102307673B1 (en) * | 2020-04-23 | 2021-10-01 | 강경순 | Natural composition for protecting skin |
KR102731151B1 (en) * | 2022-04-11 | 2024-11-18 | 김의원 | Ecofriendly functional bio material and method for manufacturing same |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102132004B1 (en) * | 2017-11-06 | 2020-07-08 | 난통 하이싱 일렉트로닉스 리미티드 라이어빌러티 컴퍼니 | Pretreatment method to improve the pore generation density of electrode foil for aluminum electrolytic capacitors |
KR102232006B1 (en) * | 2016-12-28 | 2021-03-25 | 디아이씨 가부시끼가이샤 | Dispersion and ink composition for inkjet using the same, light conversion layer, and liquid crystal display element |
-
2008
- 2008-03-11 KR KR1020080022266A patent/KR100986249B1/en active IP Right Grant
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102232006B1 (en) * | 2016-12-28 | 2021-03-25 | 디아이씨 가부시끼가이샤 | Dispersion and ink composition for inkjet using the same, light conversion layer, and liquid crystal display element |
KR102132004B1 (en) * | 2017-11-06 | 2020-07-08 | 난통 하이싱 일렉트로닉스 리미티드 라이어빌러티 컴퍼니 | Pretreatment method to improve the pore generation density of electrode foil for aluminum electrolytic capacitors |
Non-Patent Citations (3)
Title |
---|
논문1:Korea J. Medicinal Crop Sci* |
한국식품영양과학회지 35(2) 219~223(2006.)* |
한국식품저장유통학회지 11(2) 207~213 (2004.)* |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101062660B1 (en) | 2008-10-10 | 2011-09-06 | 주식회사 에버코스 | Cosmetic composition comprising a preservative substitute |
KR101393008B1 (en) | 2012-09-06 | 2014-05-12 | 주식회사 코리아나화장품 | Skin external application containing compounds from extract of Dryopteris crassirhizoma with anti bacterial activity |
KR20170025541A (en) | 2015-08-28 | 2017-03-08 | 부경대학교 산학협력단 | An antibacterial composition comprising the extract or fraction of Sargassum serratifolium |
KR20190142932A (en) | 2018-06-19 | 2019-12-30 | 대한민국(농촌진흥청장) | Mask pack composition comprising for moisturizing effect and enhancing elasticity on the skin |
KR20220115447A (en) | 2021-02-10 | 2022-08-17 | 서울대학교산학협력단 | Antiviral agent with inhibitory activitity on SARS-coronavirus-2 by phloroglucinol compounds from Dryopteris crassirhiza and compositions for treatment and prevention of COVID-19 containing the same as an active ingredient |
Also Published As
Publication number | Publication date |
---|---|
KR20080028391A (en) | 2008-03-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR100986249B1 (en) | Spectrum extract and natural antibacterial and antiseptic composition using the same. | |
KR101532005B1 (en) | Natural preservative comprising citrus junos seed extract and manufacturing method thereof | |
KR101897359B1 (en) | Cosmetic compositions and wet tissue solution containing natural preservatives | |
KR101068151B1 (en) | Compositions comprising plant extracts having antibacterial and antiseptic activity and uses thereof | |
KR101525976B1 (en) | Natural preservative composition containing Agrimonia Pilosa Extract, Coptis Chinensis Root Extract and Green Tea Extract | |
KR101806800B1 (en) | Complex natural preservative comprising scutellaria baicalensis extract and method manufacture the same | |
KR101229045B1 (en) | Extracting method of nelumbo nucifera flower, leaf, stem, root, seed and cosmetic composition for anti-wrinkle containing extracts thereby | |
KR101266180B1 (en) | Vegetable antibacterial composition and cosmetic composition for improving skin using the same | |
KR102271886B1 (en) | Cosmetic composition containing complex medicinal herbs extract for skin whitening and anti-wrinkle effect and manufacturing method thereof | |
KR101511747B1 (en) | Natural Preservative Composition Containing the Extract of Lisimachiae Herba, Galla Rhois, Cassia Bark and Caryophylli Flos | |
KR20120009554A (en) | Cosmetic composition containing herbal extracts having antioxidant and anti-allergic effects | |
KR101822092B1 (en) | Cosmetic composition for preventing thermal skin aging containing aloe vera leaves complex extract | |
KR101427462B1 (en) | Composite Natural Antiseptics From Forsythia suspensa Vahl, Leonurus sibiricus L., Crataegi fructus and Akebia quinata Decaisne, Cosmetic Compositions Containing Them | |
KR102561081B1 (en) | Cosmetic Composition having antioxidant, antibacterial, skin moisturing and anti-inflammatory Effect | |
KR102163969B1 (en) | Cosmetic Compositions Containing Fermented Extracts of Vernicia fordii | |
KR101839612B1 (en) | Natural Preservative Composition Containing Plant Extract Complex as Active Ingredient | |
KR101818146B1 (en) | The composition of botanical preservatives which consist of White Willow Bark, Aspen Bark, Azadirachta Indica Leaf and Atremisia Annua extracts | |
KR102305336B1 (en) | Natural antibacterial agent and cosmetic composition for improving atopic dermatitis | |
KR102154139B1 (en) | Composition comprising fermentation of sap of painted maple, cacao nibs extract and granat extract | |
KR20130110696A (en) | Cosmetic composition containing extract of euphorbia humifusa, scutellaria baicalensis and coptis chinensis | |
KR101599394B1 (en) | Cosmetic composition for anti-oxidant, anti-inflammatory and anti-bacterial effect | |
KR20110120481A (en) | Natural preservative cosmetic composition containing kimchi lactic acid bacteria fermentation broth and willow bark extract as antibacterial ingredient | |
KR20180031119A (en) | Natural antimicrobial composition and cosmetic composition containing the same | |
KR20090028077A (en) | Preservative-free cosmetic composition containing oliuropine, magnolol and honokiol as antibacterial ingredients | |
KR20170043057A (en) | Composition for wet tissue |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
PA0109 | Patent application |
Patent event code: PA01091R01D Comment text: Patent Application Patent event date: 20080311 |
|
PA0201 | Request for examination | ||
PG1501 | Laying open of application | ||
E902 | Notification of reason for refusal | ||
PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20100127 Patent event code: PE09021S01D |
|
E701 | Decision to grant or registration of patent right | ||
PE0701 | Decision of registration |
Patent event code: PE07011S01D Comment text: Decision to Grant Registration Patent event date: 20100924 |
|
GRNT | Written decision to grant | ||
PR0701 | Registration of establishment |
Comment text: Registration of Establishment Patent event date: 20101001 Patent event code: PR07011E01D |
|
PR1002 | Payment of registration fee |
Payment date: 20101004 End annual number: 3 Start annual number: 1 |
|
PG1601 | Publication of registration | ||
FPAY | Annual fee payment |
Payment date: 20130716 Year of fee payment: 4 |
|
PR1001 | Payment of annual fee |
Payment date: 20130716 Start annual number: 4 End annual number: 4 |
|
FPAY | Annual fee payment |
Payment date: 20140724 Year of fee payment: 5 |
|
PR1001 | Payment of annual fee |
Payment date: 20140724 Start annual number: 5 End annual number: 5 |
|
FPAY | Annual fee payment |
Payment date: 20150824 Year of fee payment: 6 |
|
PR1001 | Payment of annual fee |
Payment date: 20150824 Start annual number: 6 End annual number: 6 |
|
FPAY | Annual fee payment |
Payment date: 20161027 Year of fee payment: 7 |
|
PR1001 | Payment of annual fee |
Payment date: 20161027 Start annual number: 7 End annual number: 7 |
|
FPAY | Annual fee payment |
Payment date: 20170728 Year of fee payment: 8 |
|
PR1001 | Payment of annual fee |
Payment date: 20170728 Start annual number: 8 End annual number: 8 |
|
FPAY | Annual fee payment |
Payment date: 20180927 Year of fee payment: 9 |
|
PR1001 | Payment of annual fee |
Payment date: 20180927 Start annual number: 9 End annual number: 9 |
|
FPAY | Annual fee payment |
Payment date: 20191001 Year of fee payment: 10 |
|
PR1001 | Payment of annual fee |
Payment date: 20191001 Start annual number: 10 End annual number: 10 |
|
PR1001 | Payment of annual fee |
Payment date: 20201105 Start annual number: 11 End annual number: 11 |
|
PC1903 | Unpaid annual fee |
Termination category: Default of registration fee Termination date: 20220712 |